Patients with Graves disease who taper methimazole to a maintenance dose of 1.25 mg/day before discontinuing the drug experience improved remission rates compared to those on higher doses.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/reducing-mmi-dose-pre-stop-cuts-relapse-graves-disease-2025a1000ocw?src=rss
Author :
Publish date : 2025-09-15 16:04:00
Copyright for syndicated content belongs to the linked Source.
